SCHEMBL7681

SCHEMBL7681

Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1[C@@H](O)C(=O)NCCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.51
LPAR1 Q92633 2/20 0.51
ABCC3 O15438 1/20 0.51
ABCC4 O15439 1/20 0.51
ABCB11 O95342 1/20 0.51
CYP2C8 P10632 1/20 0.51
ABCB4 P21439 1/20 0.51
ABCC2 Q92887 1/20 0.51
SLCO1B3 Q9NPD5 1/20 0.51
SLCO1B1 Q9Y6L6 1/20 0.51
FAAH O00519 1/20 0.39
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TSHR P16473 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.36
AKR1C3 P42330 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7469 1.00 CYP2C9 (0.51) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL7110 0.91 LPAR1 (0.52) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL7076 0.90 ABCC3 (0.44) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL7474 0.90 ABCC3 (0.44) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL6377 0.84 CNR1 (0.42) CYP2C9FAAHRAB9ANPC1MAPK1
SCHEMBL7014 0.84 TSHR (0.51) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL2497 0.84 LPAR1 (0.52) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL1596 0.83 LPAR1 (0.52) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL6602 0.82 CYP2C9 (0.49) CYP2C9LPAR1ABCC3ABCC4ABCB11
SCHEMBL5995 0.82 LPAR1 (0.61) CYP2C9LPAR1ABCC3ABCC4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed